Search for European Projects

6 European Projects Found

Searched on 125080 European Projects

 FINISHED 
Background The presence of the lesser spotted eagle (Aquila pomarina) in Schorfheide-Chorin, northeast Germany, is of great significance. The species can be found 25 km away from the project area, but it has very complex habitat requirements. As a result its numbers are in decline in Brandenburg and Mecklenburg-West Pomerania, where there is increasing lo...
Read Project

 5

 FINISHED 
"Merkel cell carcinoma (MCC) is a highly aggressive, often lethal neuroendocrine cancer of the skin associated with the recently discovered, common Merkel cell polyomavirus (MCV). With an incidence of 0.44 per 100,000 MCC is a very rare cancer. Notably, however, although MCC is 40 times less common than malignant melanoma, MCC has a dramatically higher mortality rate than melanoma rendering MCC to...
Read Project

 11

 FINISHED 
Security and quality of life in industrialized countries depend on continuous and coordinate performance of a set of infrastructures (energy systems, ICT systems, transportation etc) which can be therefore defined “critical infrastructures” (CI).“STRUCTURES - Strategies for The impRovement of critical infrastrUCTUre Resilience to Electromagnetic attackS” aims at analyzing possible effects of elect...
Read Project

 13

 FINISHED 

Safety Evaluation of Adverse Reactions in Diabetes (SAFEGUARD)

Start date: Oct 1, 2011, End date: Sep 30, 2015,

"In 2010 a widely marketed drug for the treatment of type 2 diabetes (T2DM) (rosiglitazone) was taken from the market as it was associated with an increased risk of myocardial infarction, a T2DM complication it was actually supposed to prevent. This example shows several things. First, the approval requirements do not guarantee a longer term positive benefit risk profile. Second, large scale postm...
Read Project

 19

 FINISHED 

Profiling Responders In Antibody Therapies (PRIAT)

Start date: Nov 1, 2012, End date: Oct 31, 2014,

"Therapeutic antibodies are the largest and fastest growing class of pharmaceutical biotechnology products, with annual sales above 30 billion US$. In some cases, antibody products have revolutionized the management of patients, e.g. TNF-blocking antibodies in Arthritis or Rituxan in lymphoma. However, for most antibody therapies, only a subset of patients benefit from treatment. Thus, there is an...
Read Project

 8

 FINISHED 
In der Sozialwirtschaft sind europaweit mehr als 50.000 Personen anleitend in SIEs(Social Integration Enterprises) tätig, die über 1 Mio. Menschen bei der Verbesserungihrer beruflichen Situation und Integration begleiten und qualifizieren; diesesFachpersonal ist zuständig für fachliche und überfachliche Qualifizierung der befristetBeschäftigten und für die Dokumentation der vorhandenen Fähigkeiten...
Read Project

 6